Volume 29, Issue 7 pp. 1101-1109

Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial

Lei Chen

Lei Chen

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

*These authors contributed equally.

Search for more papers by this author
Tianli Xiao

Tianli Xiao

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

*These authors contributed equally.

Search for more papers by this author
Wensheng Chen

Wensheng Chen

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

Search for more papers by this author
Qingling Long

Qingling Long

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

Search for more papers by this author
Rongjun Li

Rongjun Li

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

Search for more papers by this author
Dianchun Fang

Dianchun Fang

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

Search for more papers by this author
Rongquan Wang

Rongquan Wang

Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China

Search for more papers by this author
First published: 02 July 2009
Citations: 47
Correspondence
Prof. Rongquan Wang, MD, PhD, Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
Tel: +023 65478216 (H), +023 68754124
Fax: +023 65410853
e-mail: [email protected]

Abstract

Background/Aims: The transjugular intrahepatic portosystemic shunt (TIPS) is technically divided into TIPS through the left branch of the portal vein (TIPS-LBPV) and TIPS through the right branch of the portal vein (TIPS-RBPV). In order to compare their advantages and disadvantages, this randomized, controlled trial was designed to investigate their outcomes in advanced cirrhotic patients.

Methods: Seventy-two patients were randomly placed into TIPS-LBPV (36 patients) and TIPS-RBPV (36 patients, with four failures) groups, and they were prospectively followed for 2 years after TIPS implantation.

Results: Patients who underwent the two different kinds of TIPS were balanced during recruitment for this study. The incidences of overall encephalopathy and de novo encephalopathy in the TIPS-LBPV group were significantly lower than that of the TIPS-RBPV group during follow-up (P=0.036 and 0.012 respectively). The incidences of rebleeding or re-intervention and improvement of ascites were similar between groups (P>0.05). Patients undergoing TIPS-RBPV required more rehospitalization and incurred more costs than those who underwent TIPS-LBPV (P=0.030 and 0.039 respectively). There was no significant difference between the two groups in survival based on a survival curve constructed according to the Kaplan–Meier method (P>0.05).

Conclusion: Patients undergoing TIPS-LBPV had a lower incidence of encephalopathy, less rehospitalization and lower costs after TIPS implantation compared with patients undergoing TIPS-RBPV.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.